Recursion Pharmaceuticals, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Salt Lake City, UT
RXRX chart
What traders are saying about $RXRX
Latest postsRecursion Pharmaceuticals, Inc. news
- Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Recursion Pharmaceuticals, Inc. (RXRX) stock price, news, quote and history - Yahoo Finance
Yahoo Finance Singapore ·
- Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider
Yahoo Finance ·
- Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
Yahoo Finance ·
- Recursion Pharmaceuticals, Inc. Class A Estimates – BX:RXRX
TradingView ·
- Recursion Pharmaceuticals, Inc. (RXRX) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Recursion Pharmaceuticals (RXRX) Lands Sanofi Milestone And Trial Updates, Is The Valuation Already Too Rich?
Simply Wall Street ·
- Sanofi Drug Option Might Change The Case For Investing In Recursion Stock (RXRX)
Simply Wall Street ·
- Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
Yahoo Finance ·
- Has Recursion Pharmaceuticals (RXRX) Fallen Far Enough on Sales?
Yahoo Finance ·
- Why Recursion Pharmaceuticals Stock Is In Focus After Drug Data And Sanofi Milestone
Yahoo Finance ·
- Is Recursion Pharmaceuticals (RXRX) Undervalued Following Sanofi’s First Option Milestone?
Yahoo Finance ·
Recursion Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $74.7M | $58.8M | $44.6M | $39.8M |
| Net income | -$644.8M | -$463.7M | -$328.1M | -$239.5M |
| Diluted EPS | $-1.44 | $-1.69 | $-1.58 | $-1.36 |
| Total assets (year end) | $1.47B | $1.45B | $653.7M | $701.3M |
| Cash and equivalents (year end) | $743.3M | $594.4M | $391.6M | $549.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Recursion Pharmaceuticals, Inc.
- Ticker
- RXRX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Salt Lake City, UT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1601830
- Former names
- Recursion Pharmaceuticals, LLC
Frequently asked questions
What exchange is Recursion Pharmaceuticals, Inc. listed on?
Recursion Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol RXRX.
What industry is Recursion Pharmaceuticals, Inc. in?
Recursion Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Recursion Pharmaceuticals, Inc. headquartered?
Recursion Pharmaceuticals, Inc.'s business address on file with the SEC is in Salt Lake City, UT.
When does Recursion Pharmaceuticals, Inc.'s fiscal year end?
Recursion Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Recursion Pharmaceuticals, Inc. report?
Recursion Pharmaceuticals, Inc. reported $74.7M in revenue for calendar year 2025, according to its SEC filings.